Letter to the Editor: European Headache Federation Guidelines on the Use of Monoclonal Antibodies Acting on the Calcitonin Gene-Related Peptide or Its Receptor for Migraine Prevention

Journal of Headache and Pain - Italy
doi 10.1186/s10194-019-0994-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Letter to the Editor Regarding European Headache Federation Guideline on the Use of Monoclonal Antibodies Acting on the Calcitonin Gene Related Peptide or Its Receptor for Migraine Prevention

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2019English

How to Integrate Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide or Its Receptor in Daily Clinical Practice

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2019English

New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies

Frontiers in Pharmacology
Pharmacology
2019English

Calcitonin Gene-Related Peptide (CGRP) and Migraine

Headache
Neurology
2006English

Calcitonin Gene-Related Peptide: An Update on the Biology

Current Opinion in Neurology
Neurology
2009English

Refractory Chronic Migraine: A Consensus Statement on Clinical Definition From the European Headache Federation

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2014English

The Calcitonin/Calcitonin Gene-Related Peptide Family in Invertebrate Deuterostomes

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Is There an Inherent Limit to the Efficacy of Calcitonin Gene-Related Peptide Receptor Antagonists in the Acute Treatment of Migraine? A Comment

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2009English

Calcitonin-Gene-Related Peptide

Inpharma Weekly
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy